C. Robert-Tissot

发表

A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.

Manish R. Patel, H. Burris, J. Frederick, 2019, Journal of Clinical Oncology.

In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain

P. Rovero, R. Hofmann-Lehmann, G. Sabatino, 2011, Antiviral therapy.

IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function

Trevor J Pugh, B. Haibe-Kains, T. Pugh, 2020, Cancer Immunology Research.

Induction of resistance to herpesvirus and calicivirus in the domestic cat by stimulation of the innate immune system Inaugural

C. Robert-Tissot, H. Lutz, 2011 .

The innate antiviral immune system of the cat: Molecular tools for the measurement of its state of activation

B. Wittig, R. Hofmann-Lehmann, B. Riond, 2011, Veterinary Immunology and Immunopathology.

Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy.

Russell G. Jones, L. Nguyen, P. Ohashi, 2019, Cancer research.

Anticancer Teamwork: Cross-Presenting Dendritic Cells Collaborate with Therapeutic Monoclonal Antibodies.

D. Speiser, C. Robert-Tissot, 2016, Cancer discovery.

Title Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families Permalink

P. Moore, R. Hofmann-Lehmann, B. Riond, 2012 .

Induction of resistance to viral infections in the domestic cat by stimulation of the immune system

C. Robert-Tissot, 2011 .

A phase 1, open-label, multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with pembrolizumab in subjects with unresectable solid tumors (Keynote-603).

J. Frederick, D. Cho, T. Zaks, 2019, Journal of Global Oncology.

Coenzyme A fuels T cell anti-tumor immunity.

Trevor J Pugh, T. Pugh, J. Wargo, 2021, Cell metabolism.

798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update

J. Bauman, H. Burris, J. Frederick, 2020 .

High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation

B. Clarke, Azin Sayad, M. Bernardini, 2019, Journal of Immunotherapy for Cancer.

Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families

P. Moore, R. Hofmann-Lehmann, B. Riond, 2012, Veterinary Research.

Mobilizing and evaluating anticancer T cells: pitfalls and solutions

D. Speiser, L. Nguyen, P. Ohashi, 2013, Expert review of vaccines.

IRF4 and BATF are critical for CD8+ T-cell function following infection with LCMV

T. Mak, D. Speiser, A. Pandyra, 2014, Cell Death and Differentiation.

Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer

B. Clarke, H. Berman, Azin Sayad, 2019, Oncoimmunology.

Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo

J. Haynes, G. Hannon, Kai Huang, 2018, PLoS biology.

Induction of a systemic antiviral state in vivo in the domestic cat with a class A CpG oligonucleotide

R. Hofmann-Lehmann, B. Riond, M. Meli, 2012, Veterinary Immunology and Immunopathology.

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

M. Carlino, T. Zaks, C. Robert-Tissot, 2024, The Lancet.